We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBE icon
3051
Invesco Biotechnology & Genome ETF
PBE
$359M
$366K ﹤0.01%
6,210
+731
+13% +$45K
SAN icon
3052
Banco Santander
SAN
$211B
$366K ﹤0.01%
157,651
-53,308
-25% -$133K
SHCR
3053
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$366K ﹤0.01%
192,672
-379,036
-66% -$664K
HDMV icon
3054
First Trust Horizon Managed Volatility Developed International ETF
HDMV
$17.4M
$365K ﹤0.01%
14,880
-996
-6% -$27.3K
BIZD icon
3055
VanEck BDC Income ETF
BIZD
$1.71B
$364K ﹤0.01%
26,843
+12,768
+91% +$199K
TNK icon
3056
Teekay Tankers
TNK
$2.9B
$363K ﹤0.01%
+13,173
New +$311K
BLFS icon
3057
BioLife Solutions
BLFS
$1.72B
$362K ﹤0.01%
15,923
-60,940
-79% -$1.3M
CYRX icon
3058
CryoPort
CYRX
$766M
$362K ﹤0.01%
14,851
-1,815
-11% -$62.5K
FIDU icon
3059
Fidelity MSCI Industrials Index ETF
FIDU
$2.39B
$361K ﹤0.01%
+8,255
New +$398K
GAIN icon
3060
Gladstone Investment Corp
GAIN
$658M
$361K ﹤0.01%
29,832
-5,245
-15% -$75.4K
GRPM icon
3061
Invesco S&P MidCap 400 GARP ETF
GRPM
$511M
$361K ﹤0.01%
4,809
-8,225
-63% -$684K
PFS icon
3062
Provident Financial Services
PFS
$3.26B
$361K ﹤0.01%
18,500
PGZ
3063
Principal Real Estate Income Fund
PGZ
$68.3M
$360K ﹤0.01%
32,581
+9,707
+42% +$124K
AOMR
3064
Angel Oak Mortgage REIT
AOMR
$209M
$359K ﹤0.01%
29,942
+6,700
+29% +$94.5K
ARMK icon
3065
Aramark
ARMK
$16.1B
$359K ﹤0.01%
15,955
-384,951
-96% -$9.58M
LXP icon
3066
LXP Industrial Trust
LXP
$3.58B
$359K ﹤0.01%
7,840
+27
+0.3% +$1.4K
KYMR icon
3067
Kymera Therapeutics
KYMR
$9.51B
$358K ﹤0.01%
+16,464
New +$434K
ARTNA icon
3068
Artesian Resources
ARTNA
$369M
$356K ﹤0.01%
7,398
BLE
3069
DELISTED
BlackRock Municipal Income Trust II
BLE
$356K ﹤0.01%
35,562
+3,267
+10% +$36.5K
AEO icon
3070
American Eagle Outfitters
AEO
$2.73B
$355K ﹤0.01%
36,459
-30,498
-46% -$355K
OSIS icon
3071
OSI Systems
OSIS
$3.77B
$355K ﹤0.01%
4,927
+9
+0.2% +$788
MLCO icon
3072
Melco Resorts & Entertainment
MLCO
$2.14B
$353K ﹤0.01%
53,279
+13,902
+35% +$76.6K
INSI
3073
DELISTED
Insight Select Income Fund
INSI
$353K ﹤0.01%
22,982
+1
+0% +$16
ENVX icon
3074
Enovix
ENVX
$966M
$352K ﹤0.01%
+21,971
New +$324K
SCHH icon
3075
Schwab US REIT ETF
SCHH
$11.4B
$352K ﹤0.01%
18,818
+3,048
+19% +$65.9K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.